WuXi AppTec (OTCMKTS:WUXAY) Sets New 52-Week High – What’s Next?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY)’s stock price hit a new 52-week high during trading on Friday . The stock traded as high as $20.00 and last traded at $19.70, with a volume of 4558 shares trading hands. The stock had previously closed at $18.56.

Wall Street Analyst Weigh In

Separately, Zacks Research upgraded shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

WuXi AppTec Price Performance

The firm has a 50-day simple moving average of $17.13 and a 200 day simple moving average of $15.54.

WuXi AppTec (OTCMKTS:WUXAY) last released its quarterly earnings results on Monday, April 27th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.05. The firm had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.59 billion.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.